Page last updated: 2024-11-08

chloramphenicol and Dominant Hereditary Sensory Neuropathy, Type III

chloramphenicol has been researched along with Dominant Hereditary Sensory Neuropathy, Type III in 1 studies

Amphenicol: Chloramphenicol and its derivatives.

Research Excerpts

ExcerptRelevanceReference
" Four seriously ill children (bronchiolitis, hypoaldosteronism, dysautonomia, Reye syndrome), ages 4 months to 11 years, received chloramphenicol (CAP) intravenously."7.67Acidosis as a presenting feature of chloramphenicol toxicity. ( Evans, LS; Kleiman, MB, 1986)
" Four seriously ill children (bronchiolitis, hypoaldosteronism, dysautonomia, Reye syndrome), ages 4 months to 11 years, received chloramphenicol (CAP) intravenously."3.67Acidosis as a presenting feature of chloramphenicol toxicity. ( Evans, LS; Kleiman, MB, 1986)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Evans, LS1
Kleiman, MB1

Other Studies

1 other study available for chloramphenicol and Dominant Hereditary Sensory Neuropathy, Type III

ArticleYear
Acidosis as a presenting feature of chloramphenicol toxicity.
    The Journal of pediatrics, 1986, Volume: 108, Issue:3

    Topics: Acidosis; Bronchiolitis, Viral; Child; Child, Preschool; Chloramphenicol; Dysautonomia, Familial; Fe

1986